Regardless of the genetic alteration, TP53 transcriptional inactivation can lead to genomic instability and impaired apoptotic responses that often are predisposing to a wide array of cancers (Kastenhuber and Lowe, 2017; Muller and Vousden, 2014). The gene discussed is TP53; the disease is cancer.